Neurological Prognostication of Patients in Therapeutic Hypothermia After Cardiac Arrest
1 other identifier
interventional
100
2 countries
2
Brief Summary
3500 people suffer from out of hospital cardiac arrest each year in Denmark. Therapeutic hypothermia to 33 degrees celsius is now standard treatment of comatose cardiac arrest patients. The investigators are challenged in our attempt to predict outcome of these patients by both low body temperature in itself and the sedative and relaxing drugs used to keep the patient in a coma. This study is a substudy in a large international multicenter randomized trial that investigates the possible benefit of 48 hours of therapeutic hypothermia versus todays standard of 24 hours. In this substudy the investigators will approach early prediction of neurological outcome using a combination of new examinations backed up by well established ones to engage this challenge from different angles and find a battery of combined examinations, that together will enable us to accurately predict outcome at an earlier stage. Our examinations have been chosen from the three fields of neurophysiology, biochemistry and neurology and consist of electroencephalography (EEG), somatosensory evoked potentials (SEP), biomarkers and clinical examinations such as brain stem reflexes chosen for their prognostic reliability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2013
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 2, 2015
CompletedFirst Posted
Study publicly available on registry
March 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMay 3, 2017
February 1, 2015
3.3 years
March 2, 2015
May 1, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Glasgow-Pittsburgh Cerebral Performance Categories (CPC) after 6 months
To evaluate neurologic recovery using the Glasgow-Pittsburgh Cerebral Performance Categories (CPC) 6 months after cardiac arrest. The CPC-score will be dichotomized in good (CPC 1-2) and poor (CPC 3-5) outcome.
6 months
Secondary Outcomes (1)
Area under the curve
72 hours
Other Outcomes (1)
Presence of brainstem reflexes
72 hours
Study Arms (2)
24 hours of therapeutic hypothermia
NO INTERVENTION24 hours of therapeutic hypothermia to a target temperature of 32-34 degrees in comatose cardiac arrest patients is standard treatment in Denmark.
48 hours of therapeutic hypothermia
EXPERIMENTAL48 hours of therapeutic hypothermia to a target temperature of 32-34 degrees
Interventions
Eligibility Criteria
You may qualify if:
- Out-of-hospital cardiac arrest with presumable cardiac origin
- Restored spontaneous circulation after resuscitation (No need for cardiac compressions during 20 min, and clinical sign of circulation)
- Glasgow Coma Score (GCS) \< 8
- Age \>= 18, \< 80 years
You may not qualify if:
- Estimated time interval from collapse to return of spontaneous circulation\>60 min
- Cardiac arrest with presumable non-cardiac origin (hypoxia etc.).
- In hospital cardiac arrest
- Terminal disease
- Unwitnessed asystolia
- Time from cardiac arrest to initiation of cooling\>240 min.
- Pregnancy
- Persistent cardiogenic shock, systolic blood pressure\<80 mmHg despite vasoactive treatment
- Cerebral performance category (CPC) 3-4 before cardiac arrest.
- Suspicious or confirmed intracerebral bleeding
- Suspicious or confirmed acute stroke
- Acute CABG
- No informed consent from relatives
- No informed consent from general practitioner
- Patient unstable
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Aarhus University Hospitalcollaborator
- Roche Diagnostics GmbHcollaborator
- ThermoFisher Scientific Brahms Biomarkers Francecollaborator
- Regionshospitalet Hammel Neurocentercollaborator
Study Sites (2)
Aarhus University Hospital, Skejby
Aarhus, 8200, Denmark
Stavanger University Hospital
Stavanger, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2015
First Posted
March 18, 2015
Study Start
March 1, 2013
Primary Completion
June 1, 2016
Study Completion
December 1, 2016
Last Updated
May 3, 2017
Record last verified: 2015-02